mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
0.078 |
0.2 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
blebbistatin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.2 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.2 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |
mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.2 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.2 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.075 |
0.2 |